Antigluconeogenic activity of gonadal steroid analogues in relation to liver glucocorticoid—receptor binding  by Agarwal, M.K. & Coupry, F.
Volume 82, number 2 FEBS LETTERS October 1977 
ANTIGLUCONEOGENIC ACTIVITY OF GONADAL STEROID ANALOGUES IN 
RELATION TO LIVER GLUCOCORTICOID-RECEPTOR BINDING 
M. K. AGARWAL and F. COUPRY 
Inserm U-36, I7 Rue du Fer-Sfoulin, Paris 75005, France 
Received 8 August 1977 
1. Introduction 
Gonadal steroids have been studied intensively 
over the past decades both for their clinical value 
in contraception and to delineate the mechanism 
of steroid hormone action in the appropriate target 
tissue [ 1,2] . Although most of their physiological 
effects are restricted to the respective organ in the 
male and the female, various sex steroids have been 
known to alter several hepatic responses [ 1,2] and 
to bind to high affinity receptors in liver super- 
natant fractions [3] . Antiglucocorticoid activity of 
testosterone in the hepatoma cell cultures [4] and 
of progesterone in isolated thymocytes [5] has 
also been documented although such is not the case 
in vivo [5] . The present report adds a new parameter 
in the range of metabolic changes inflicted by gonadal 
steroids in the liver, by exhibiting antiglucocorticoid 
activity in vivo, and reveals that this may proceed 
without concurrent antagonism in glucocorticoid- 
receptor association. 
2. Materials and methods 
Male, Wistar rats (200-250 g) were bilaterally 
adrenalectomized under ether anaesthesia nd main- 
tained on 1% NaCl ad libitum. Animals were injected 
intraperitoneally 3-5 days post-surgery with the test 
steroid suspended in water and sacrificed 4 h later. 
Livers were quickly removed, weighed and homo- 
genized with a Teflon pestle in 5% trichloroacetic 
acid (TCA) containing 0.1% silver sulphate. After 
heating in a boiling water bath for 15 min, 2 ml of 
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the clear supernate was mixed with 6 ml 36 N H,SOa. 
Samples were thoroughly vortexed, heated in a boiling 
water bath for 6 min, cooled in an ice bath, and quan- 
titated 520 nm in a spectrophotometer against a blank 
containing only TCA-silver sulphate in place of liver 
homogenate. A standard curve was run with each expe- 
riment consisting of 25,50 and 100 pg glucose in the 
initial buffer. The glycogen levels are expressed as 1.18 
5-hydroxymethylfurfural/lOO mg fresh liver tissue, as 
previously described [6,7]. 
For binding studies, livers were perfused with the 
incubation buffer (0.01 M Tris-HCl, pH 7.4), homo- 
genized with a Teflon pestle, centrifuged at low speed 
(20 000 X g, 20 min) followed by ultracentrifugation 
105 000 X g, 60 min). The cell sap thus obtained 
(0.5 ml) was dispensed into Pyrex tubes containing 
3 X 1 Oe6 mol/ml nonradioactive competitor of choice. 
After incubation (60 min, at 3”C), 0.5 ml carbon 
(Sigma C-5260) suspension (100 mg/ml Tris buffer) 
was added to each tube. Samples were vortexed, 
allowed to stand for 10 min and finally centrifuged 
(5000 X g, 5 min). All manipulations were carried 
out at 2-4°C. Aliquots, 200 4, of the reaction mix- 
ture were put into 10 ml Unisolve (Kochlight, 
England) and counted in a Packard Tricarb Scintilla- 
tion Spectrometer equipped with background sub- 
straction and external standardization. 
All steroids were purchased from Steroloids (NY). 
11 -Methoxy ethyl derivative was kindly provided by 
Drs D. Philibert and J. P. Raynaud, Roussel UCLAF, 
(Romainville, France). [ 1 ,2,4-3H] Triamcinolone 
acetonide (16 Ci/mM; batch ZT 1423) was obtained 
from Schwarz Mann (N.J.). All other chemicals were 
Reagent grade from Merck. 
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3. Results 
Data in table 1 show that all analogues of both 
testosterone and estradiol significantly decreased liver 
glycogen levels as compared to the water-treated con- 
trol. A synthetic methoxy derivative of estradiol 
appeared to be the most potent compound in this 
regard (P < .OOl) although no efforts were made to 
quantitate the differences between the various 
materials employed. Relative potency was, however, 
indicated as follows. Liver glycogen levels were 
significantly higher when triamcinolone acetonide 
(TA) was given alone or with gonadal steroid deri- 
vative. TA induction of liver glycogen was clearly 
impaired in presence of a 20-fold excess of either 
sex hormone analogue in the order 
methoxyethyl estradiol > dihydrotestostdrone > 
6-dehydrotestosterone = 1-dehydrotestosterone >
17&estradiol> 17a-estradiol > 17/3-testosterone. 
It is however difficult to say whether these results 
are in favour of an actual repression of the operon 
controlling glycogen synthesis or simply an expression 
of an increase in energy demand than can be met with 
by the endogenous rate of synthesis. 
4. Discussion 
Whatever the mechanism, this is a clear demonstra- 
Table 1 
tion of an antiglucocorticoid action in vivo. Although 
there is much discussion in the literature on the 
interaction between sex steroids and carbohydrate 
reserves, the results are at variance due primarily to 
different experimental designs and techniques [ 1,2] , 
and are in contrast with decreased glycogen levels 
clearly evident here. The implications of this finding 
in clinical prescription of oestro-progestative 
therapy are therefore clear. 
Association of a steroid with its specific receptor 
is said to constitute the first step whereby an active 
hormone initiates tissue-specific processes [8] . It 
follows that an antagonist would inhibit this binding, 
as had previously been observed in in vitro systems 
[4] . Data in table 2 show that binding of [3H]TA 
to its hepatic receptor was almost totally abolished 
in presence of lOO-fold excess of cold TA. The 
methoxy derivative of estradiol diminished [3H]TA 
binding only slightly followed by even smaller 
decreases with 17/I-estradiol. Although the former 
was most potent both in reversing gluconeogenesis 
(table l), and in antagonizing [3H]TA-receptor 
binding (table 2), the evidence indicates that 
gonadal steroid analogues reversed gluconeogenesis 
at a time when they did not significantly diminish 
[3H]TA binding to its receptor. In view of the 
multiplicity of steroid hormone vectors [9-l 21 it is 
conceivable too that the antagonists could associate 
themselves with inhibitor proteins physically distinct 
from the active receptor. On the other hand, high- 
Antigluconeogenic effect of gonadal steroid analogues 
Test compounda Liver glycogen (mg%) 
-TA +TAb 
Control 9.03 i 0.85 18.6 f 3.5 
Estradiol (170) 2.12 f 0.55 9.42 t 1.19 
Estradiol(17a) 1.09 + 0.06 11.8 kO.75 
1 I-Methoxyethyl estradiol 1 .oo c 0.05 2.52 * 0.38 
Testosterone (17p) 2.37 f 0.31 13.4 f 1.1 
1-Dehydrotestosterone 1.64 ?r 0.62 7.69 eO.97 
6-Dehydrotestosterone 2.50 + 0.26 7.48 f 1.49 
Dihydrotestosterone 1.66 f 0.14 5.65 i 1.21 
a All materials were given as a single intraperitoneal injection of 20 mg in 1 ml 
water, 4 h prior to glycogen assay 
b Triamcinolone acetonide (1 mg) was given with the test compound as above. 
Each value is the mean f SE of 4-5 separate determinations 
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Table 2 
Effect of sex steroid analogues on the binding of a synthetic glucocorticoid to 
its cytoplasmic receptor 
Competitor Binding of 3 X lo-’ [“HI triamcinolone 
(3 X 10e6 mol/ml) acetonide (cpm/mg protein)a 
None 2535 
Triamcinolone acetonide 124 
Estradiol (17p) 1794 
Estradiol (1701) 2372 
1 I-Methoxyethyl estradiol 987 
Testosterone (170) 2372 
1-Dehydrotestosterone 2344 
6-Dehydrotestosterone 2402 
Dihydrotestosterone 2443 
a Each value is a mean of three, separate determinations. Bound radioactivity 
obtained in presence of lOOO-fold excess of nonradioactive TA was substracted 
from all values to account for non specific binding 
affinity binding sites for gonadal hormones was 
confirmed in parallel studies and has been published 
earlier [3] The repressive action may proceed by 
acceptor occupancy at sites distinct from those that 
are filled with the glucocorticoid-receptor complex 
or by actual diminution in the transfer of receptor- 
bound TA to the appropriate nuclear regions. Further 
studies are needed to distinguish between these 
various possibilities. 
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